FDA Inspection
Novitium Pharma LLCNovitium Pharma LLC – FDA Inspection, Feb 4, 2019
Record Details
This FDA Inspection record concerns Novitium Pharma LLC, with an inspection on February 4, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 39280e41-44ce-4cff-83ec-fff6aa1e07c5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1080904
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Novitium Pharma LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 16, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 1, 2024 | Not classified | New Jersey District Office | |
| March 31, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 8, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2018 | Not classified | New Jersey District Office |
Other documents for Novitium Pharma LLC
- FDA Inspection 1230049 - 2024-02-16
- FDA Inspection 1231393 - 2024-02-01
- FDA Inspection 1204308 - 2023-03-31
- FDA Inspection 1145707 - 2021-07-08
- FDA Inspection 1067953 - 2018-09-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.